Literature DB >> 10771101

Gene expression of flap endonuclease-1 during cell proliferation and differentiation.

I S Kim1, M Y Lee, I H Lee, S L Shin, S Y Lee.   

Abstract

It has been shown that flap endonuclease-1 (FEN-1), a structure-specific nuclease, acts on the removal of RNA primers during Okazaki fragment maturation in DNA synthesis. To study whether the gene expression of FEN-1 is inducible during cell proliferation, we analyzed the FEN-1 mRNA levels in actively growing cells and non-growing cells. The gene expression of FEN-1 was higher in mitotic cells than in resting cells, and was markedly decreased, especially, when terminal differentiation was induced in promyelocytic leukemia cells (HL-60 cells). The decline correlated substantially with the ceasing of DNA synthesis. In the examination of tissue-specific gene expression, the human testis, spleen, thymus and mucosal lining of colon tissues expressed this gene actively, whereas the prostate, ovary, small intestine and peripheral blood leukocyte hardly expressed it. In addition, FEN-1 was co-localized with the proliferating cell nuclear antigen (PCNA) in young rat kidney according to immunohistochemistry. These findings suggest that FEN-1 gene expression is inducible during cell proliferation for DNA synthesis, and is down-regulated during cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10771101     DOI: 10.1016/s0167-4889(00)00029-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  The 3'-->5' exonuclease of DNA polymerase delta can substitute for the 5' flap endonuclease Rad27/Fen1 in processing Okazaki fragments and preventing genome instability.

Authors:  Y H Jin; R Obert; P M Burgers; T A Kunkel; M A Resnick; D A Gordenin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 2.  The cutting edges in DNA repair, licensing, and fidelity: DNA and RNA repair nucleases sculpt DNA to measure twice, cut once.

Authors:  Susan E Tsutakawa; Julien Lafrance-Vanasse; John A Tainer
Journal:  DNA Repair (Amst)       Date:  2014-04-19

3.  FEN1 knockdown improves trastuzumab sensitivity in human epidermal growth factor 2-positive breast cancer cells.

Authors:  Xue Zeng; Xiaofang Che; Yun-Peng Liu; Xiu-Juan Qu; Lu Xu; Chen-Yang Zhao; Chun-Lei Zheng; Ke-Zuo Hou; Yuee Teng
Journal:  Exp Ther Med       Date:  2017-08-02       Impact factor: 2.447

4.  Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.

Authors:  Keqiang Zhang; Sawa Keymeulen; Rebecca Nelson; Tommy R Tong; Yate-Ching Yuan; Xinwei Yun; Zheng Liu; Joshua Lopez; Dan J Raz; Jae Y Kim
Journal:  Am J Pathol       Date:  2017-10-14       Impact factor: 4.307

5.  Human DNA Ligase I Interacts with and Is Targeted for Degradation by the DCAF7 Specificity Factor of the Cul4-DDB1 Ubiquitin Ligase Complex.

Authors:  Zhimin Peng; Zhongping Liao; Yoshihiro Matsumoto; Austin Yang; Alan E Tomkinson
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

Review 6.  Flap endonuclease 1.

Authors:  Lata Balakrishnan; Robert A Bambara
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

7.  Nuclease-deficient FEN-1 blocks Rad51/BRCA1-mediated repair and causes trinucleotide repeat instability.

Authors:  Craig Spiro; Cynthia T McMurray
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 8.  The wonders of flap endonucleases: structure, function, mechanism and regulation.

Authors:  L David Finger; John M Atack; Susan Tsutakawa; Scott Classen; John Tainer; Jane Grasby; Binghui Shen
Journal:  Subcell Biochem       Date:  2012

9.  Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers.

Authors:  Purnima Singh; Ming Yang; Huifang Dai; Dianke Yu; Qin Huang; Wen Tan; Kemp H Kernstine; Dongxin Lin; Binghui Shen
Journal:  Mol Cancer Res       Date:  2008-11       Impact factor: 5.852

10.  De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach.

Authors:  Seda Ballikaya; Jennifer Lee; Uwe Warnken; Martina Schnölzer; Johannes Gebert; Jürgen Kopitz
Journal:  Mol Cell Proteomics       Date:  2014-09-15       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.